All companies › TAK

TAK · TAKEDA PHARMACEUTICAL CO LTD

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research signal for this company.

0
Open-market buys
13
Open-market sells
0
INSIDER SCANNER signals
2026-08-10
Last filing

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

SEC Form 4 filings

Every open-market transaction disclosed for TAK in the synced window. Values are the insider's own, as filed.

DateInsiderTitleTypeSharesPriceValue
2026-08-10 Greenway Nicola Deidre Petal Chief Human Resources Officer Open-market sell 6,774 17.10 $115,835
2026-08-10 Kim Julie So-Young President and CEO Open-market sell 89,090 17.10 $1,523,439
2026-08-10 Platford Giles Richard President, IBU Open-market sell 31,083 17.10 $531,519
2026-08-10 Furney Natalie Anne Marie Global General Counsel Open-market sell 30,868 17.10 $527,843
2026-08-10 Farajallah Awny Samaan Botros Chief Medical Officer Open-market sell 14,006 17.10 $239,503
2026-08-10 Ibrahim Ramy Riad Ahmed President, PDT BU Open-market sell 7,277 17.10 $124,437
2026-08-10 Pacheco Rhonda Janice President, U.S. Business Unit Open-market sell 16,901 17.10 $289,007
2026-08-10 Duprey Lauren Rusckowski Chief Transformation Officer Open-market sell 47,586 17.10 $813,721
2026-08-10 Plump Andrew Stewart President, R&D Open-market sell 165,393 17.10 $2,828,220
2026-08-10 Pignagnoli Agosti Marcello Head, Strat. & Port. Dev Open-market sell 22,957 17.10 $392,565
2026-08-10 Bitetti Teresa Marie President, OBU Open-market sell 50,012 17.10 $855,205
2026-08-10 Shannon Elaine Mary Pres., Global Supply & Quality Open-market sell 3,978 17.10 $68,024
2026-08-10 Ricci Gabriele Chief Data & Tech. Officer Open-market sell 25,088 17.10 $429,005

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.